Rxo (RXO) Consolidated Net Income (2021 - 2025)
Rxo's Consolidated Net Income history spans 5 years, with the latest figure at -$46.0 million for Q4 2025.
- For Q4 2025, Consolidated Net Income fell 84.0% year-over-year to -$46.0 million; the TTM value through Dec 2025 reached -$100.0 million, up 65.52%, while the annual FY2025 figure was -$100.0 million, 65.52% up from the prior year.
- Consolidated Net Income reached -$46.0 million in Q4 2025 per RXO's latest filing, down from -$14.0 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $44.0 million in Q2 2022 to a low of -$243.0 million in Q3 2024.
- Average Consolidated Net Income over 5 years is -$12.9 million, with a median of -$4.0 million recorded in 2022.
- Peak YoY movement for Consolidated Net Income: skyrocketed 150.0% in 2023, then tumbled 24200.0% in 2024.
- A 5-year view of Consolidated Net Income shows it stood at $42.0 million in 2021, then plummeted by 109.52% to -$4.0 million in 2022, then surged by 150.0% to $2.0 million in 2023, then crashed by 1350.0% to -$25.0 million in 2024, then tumbled by 84.0% to -$46.0 million in 2025.
- Per Business Quant, the three most recent readings for RXO's Consolidated Net Income are -$46.0 million (Q4 2025), -$14.0 million (Q3 2025), and -$9.0 million (Q2 2025).